JGGDR
BCRX icon

JGP Global Gestao de Recursos’s BioCryst Pharmaceuticals BCRX Stock Holding History

JGP Global Gestao de Recursos’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,865
Closed -$67.1K – 41
2024
Q2 		$67.1K Hold
10,865
– – 0.09% 35
2024
Q1 		$55.2K Buy
10,865
+215
+2% +$1.21K 0.04% 55
2023
Q4 		$63.8K Buy
+10,650
New +$61.7K 0.04% 50
2019
Q2 		– Sell
-25,742
Closed -$210K – 57
2019
Q1 		$210K Buy
25,742
+2,018
+9% +$17.3K 0.08% 59
2018
Q4 		$191K Sell
23,724
-2,721
-10% -$21.2K 0.23% 47
2018
Q3 		$202K Buy
+26,445
New +$178K 0.34% 22

Other funds holding BCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

JGP Global Gestao de Recursos's BCRX Position: Q3 2024 in Review

JGP Global Gestao de Recursos sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2024, closing a stake of 10,865 shares — an estimated $67.1K sold.

JGP Global Gestao de Recursos first reported a position in BCRX in Q3 2018 and held it in 6 quarters. The position peaked at $210K in Q1 2019. 257 funds tracked by Wall St. Rank hold BCRX as of Q3 2024.

  • JGP Global Gestao de Recursos reported no remaining BioCryst Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 10,865 BioCryst Pharmaceuticals shares in Q3 2024, an estimated $67.1K.
  • JGP Global Gestao de Recursos first reported a position in BioCryst Pharmaceuticals in Q3 2018 and held it in 6 quarters.
  • JGP Global Gestao de Recursos's BioCryst Pharmaceuticals position peaked at $210K in Q1 2019.
  • 257 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2024.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2024, filed 1 Nov 2024.